ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

ImClone Protocol Generates More Questions Than Answers

March 8, 2002

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

FDA Nearly Wrecks NCI Drug Distribution Program, Finally Agrees To New Guidelines

January 30, 1976

Six Panels To Help NCI Identify Progress; NCINews Roundup

January 8, 1993

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate

September 1, 1978